Back
Benitec Biopharma, Inc. Stock Predictions
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
44
BNTC
Benitec Biopharma, Inc.
Last Price:
$13.36
Seasonality Move:
8.41%
7 Day Trial
ALL ACCESS PASS
$
7
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiBenitec Biopharma, Inc. Stock Forecast
-
Over the next 52 weeks, Benitec Biopharma, Inc. has on average historically fallen by 1.4% based on the past 11 years of stock performance.
-
Benitec Biopharma, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Benitec Biopharma, Inc. Stock Undervalued?The current Benitec Biopharma, Inc. [BNTC] share price is $13.18. The Score for BNTC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
BNTC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Benitec Biopharma, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Benitec Biopharma, Inc. has on average historically fallen by 1.4% based on the past 11 years of stock performance.
Benitec Biopharma, Inc. Stock Rating
Sell
44
Benitec Biopharma, Inc. (BNTC)
is a Sell
Is Benitec Biopharma, Inc. overpriced?
-
Benitec Biopharma, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Benitec Biopharma, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
benitec.com
52-Week Data
52-Week High:
17.15
52-Week Low:
9.49
Prediction Charts
Market Cap:
446.3M
Price in USD:
13.18
Volume:
483.2K
Beta:
1.54
Technical Analysis
SMA50:
14.24
SMA100:
13.43
SMA200:
13.57
52-Wk Change:
33.81%
Stock Predictions
-
Is Benitec Biopharma, Inc. stock public?Yes, Benitec Biopharma, Inc. is a publicly traded company.
-
What is the Benitec Biopharma, Inc. stock quote today?The Benitec Biopharma, Inc. stock price is 13.18 USD today.
-
How to buy Benitec Biopharma, Inc. stock online?You can buy Benitec Biopharma, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 13.02 | 13.16 | 13.29 | 12.57 |
| Nov-17 | 13.31 | 13.53 | 13.94 | 12.47 |
| Nov-18 | 13.53 | 13.53 | 13.87 | 13.06 |
| Nov-19 | 13.60 | 13.10 | 13.95 | 12.97 |
| Nov-20 | 13.30 | 13.14 | 13.56 | 12.93 |
| Nov-21 | 13.07 | 13.26 | 13.50 | 12.85 |
| Nov-24 | 13.29 | 13.07 | 13.47 | 12.73 |
| Nov-25 | 13.13 | 12.93 | 13.43 | 12.84 |
| Nov-26 | 12.86 | 13.02 | 13.09 | 12.65 |
| Nov-28 | 12.87 | 12.96 | 13.17 | 12.82 |
| Dec-1 | 12.82 | 12.23 | 12.82 | 12.18 |
| Dec-2 | 12.25 | 11.65 | 12.96 | 11.54 |
| Dec-3 | 11.74 | 12.58 | 13.00 | 11.65 |
| Dec-4 | 12.49 | 13.18 | 13.22 | 12.49 |
Benitec Biopharma, Inc. Earnings
Benitec Biopharma, Inc. Earnings Report: Per Share Benitec Biopharma, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Benitec Biopharma, Inc. Forecast Revenue Growth
Benitec Biopharma, Inc. Stock Analysis: Historical quarterly revenues per share for Benitec Biopharma, Inc. and historical quarterly revenue growth:
* Benitec Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.